MDEV
First Trust Indxx Medical Devices ETF
MDEV tracks an equal-weighted index that gives global exposure to the medical equipment industry.
Global
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 2.0 M
ASSETS UNDER MGMT
70 bp
EXPENSES
Fund Basics
| Inception date | Jun 22, 2021 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| GLOBUS MEDICAL INC - A | 3.5 % |
| ALIGN TECHNOLOGY INC | 3.0 % |
| HOYA CORP | 2.8 % |
| PENUMBRA, INC. | 2.8 % |
| MASIMO CORPORATION | 2.7 % |
| WATERS CORP | 2.6 % |
| WUXI APPTEC CO., LTD. CLASS H | 2.6 % |
| FISHER & PAYKEL HEALTHCARE C | 2.4 % |
| ALCON, INC. | 2.4 % |
| EDWARDS LIFESCIENCES CORP | 2.3 % |
Constituent Breakdown
| Number of holdings | 53 |
| Herfindahl-Hirschman Index | 217 |
| Wgt avg mkt cap (mns) | $40,811 |
| Large cap (>$10bn) | 82.8% |
| Mid cap ($2-10bn) | 17.1% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 97.3% |
| Emerging mkts. | 2.6% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 58.7 % |
 |
JAPAN | 7.9 % |
 |
SWITZERLAND | 6.4 % |
 |
IRELAND | 4.1 % |
 |
FRANCE | 3.8 % |
 |
DENMARK | 3.6 % |
 |
GERMANY | 3.2 % |
 |
CHINA | 2.6 % |
 |
NEW ZEALAND | 2.4 % |
 |
NETHERLANDS | 2.3 % |
Historical Performance
Standardized Performance (as of 03/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -9.4% | -5.7% | -5.8% | -2.3% | -- | -- | -- | -5.8% |
| Dividend Yield | 0.0% | 0.0% | 0.0% | 0.0% | -- | -- | -- | 0.0% |
| Total Returns | -9.4% | -5.7% | -5.8% | -2.3% | -- | -- | -- | -5.8% | Ann. Volatility | 16.2% | 19.0% | 16.5% | 16.0% | -- | -- | -- | 19.0% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.78 | 61% |
| MSCI EAFE | 0.83 | 60% |
| MSCI Emg Mkts | 0.61 | 42% |
Liquidity Measures
| Avg. volume (000) | 0 |
| ADV traded (mns) | $0 |
| Turnover | 0.0% |
| Avg. Bid/Ask (% of price) | 0.57% |
Technical Indicators
| 30d moving avg. (EMA) | $19.51 |
| Relative strength (RSI) | 52 |
| MACD/Signal | 0.08/-0.08 |
| Bollinger Bands (Upper/Lower) | $20.09/$18.31 |
| Short interest (% of AUM) | 0.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. MDEV |
Expenses vs. MDEV |
ALTAR Score™ vs. MDEV |
|---|---|---|---|---|
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 37.3% | -30 bp | +2.0% |
| XHE | State Street SPDR S&P Health Care Equipment ETF | 35.3% | -35 bp | -1.3% |
| IHI | iShares U.S. Medical Devices ETF | 31.6% | -30 bp | +0.0% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 30.1% | -2 bp | -2.8% |
| FXH | First Trust Health Care AlphaDEX Fund | 27.0% | -8 bp | +0.4% |
| FMED | Fidelity Disruptive Medicine ETF | 22.7% | -20 bp | -6.3% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 21.4% | +5 bp | -3.7% |
| IYH | iShares U.S. Healthcare ETF | 20.9% | -30 bp | +1.3% |
| XLV | Health Care Select Sector SPDR | 20.9% | -62 bp | +2.1% |
| AGNG | Global X Aging Population ETF | 20.6% | -20 bp | -0.5% |
Risk and Returns: MDEV vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/22/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.1%
ALTAR SCORE™
61st
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 587 funds in the Global Equity category with an average
ALTAR Score™ of 4.4% and a standard deviation
of 2.6%. MDEV's ALTAR Score™ is approximately 0.3 standard
deviations above the category average. This places MDEV in the 61st percentile
among funds in the category.
Sell-Side Consensus
$25.1
PRICE TARGET
+28.1%
UPSIDE
Bid/Ask Spreads
57 bp
AVG SPREAD
22 —
168 bp
RANGE